Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(38%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
4
50%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Completed(3)

Detailed Status

Completed3
Recruiting3
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (20.0%)
N/A4 (80.0%)

Trials by Status

not_yet_recruiting113%
completed338%
enrolling_by_invitation113%
recruiting338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8